ABT vs JNJ

Abbott Laboratories remains a highly stable, diversified global healthcare leader with robust financials, strong economic moats, and excellent management. While the company continues to execute well, innovate in key areas like diabetes care (FreeStyle Libre) and structural heart, and capitalize on demographic trends, its mature size ($186B+ market cap) and established growth trajectory fundamental...

Johnson & Johnson (JNJ) remains a mega-cap, highly diversified healthcare conglomerate with an impressive market capitalization of $572.59B. While possessing a robust business model, wide economic moats, and consistent financial performance, its sheer size fundamentally misaligns with the criteria for 10x growth within a 3-5 year timeframe. A 10x return would necessitate a market cap exceeding $5....